Reference
Lewis JM, et al. First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB. European Respiratory Journal 47: 1581-1584, 2016. Available from: URL: http://doi.org/10.1183/13993003.01980-2015 - United Kingdom
Rights and permissions
About this article
Cite this article
Azithromycin/bedaquiline/clofazimine. Reactions Weekly 1610, 30 (2016). https://doi.org/10.1007/s40278-016-19453-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-19453-y